Today: 28 March 2026

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Analog Devices stock nears 52-week high as Barclays upgrade sharpens focus on earnings

Analog Devices stock nears 52-week high as Barclays upgrade sharpens focus on earnings

Analog Devices shares rose 1.8% to $337.10 Friday after Barclays upgraded the stock to Overweight and raised its price target to $375. The move comes ahead of quarterly results due Feb. 18, with analysts expecting earnings of $2.30 per share on $3.12 billion revenue. Investors are watching for signals on industrial demand and inventory trends. The stock closed about 2% below its 52-week high.
Moderna stock price jumps late after earnings beat, but FDA flu setback hangs over MRNA

Moderna stock price jumps late after earnings beat, but FDA flu setback hangs over MRNA

Moderna shares climbed 5% to $42.23 in after-hours trading Friday after beating fourth-quarter revenue estimates and reaffirming its 2026 growth outlook. The FDA refused to file Moderna’s flu vaccine application, prompting the company to seek a Type A meeting. The flu shot is under review in Europe, Canada, and Australia. Moderna reported Q4 revenue of $678 million and a $2.11 per share loss.
McDonald’s stock slides after-hours as CEO share-sale filing and fresh Buy call hit tape

McDonald’s stock slides after-hours as CEO share-sale filing and fresh Buy call hit tape

McDonald’s shares fell 1.4% to $327.58 in after-hours trading Friday after CEO Chris Kempczinski filed to sell 26,277 shares, valued at about $8.5 million, under a pre-set plan. The company reported fourth-quarter global comparable sales up 5.7% and raised its dividend 5% to $1.86. Argus upgraded the stock to “buy” with a $380 target, citing value menus and digital investment.
13 February 2026
Merck stock pops on Deutsche Bank upgrade — what to watch ahead of ASCO GU

Merck stock pops on Deutsche Bank upgrade — what to watch ahead of ASCO GU

Merck shares climbed 1.8% to $121.41 in after-hours trading Friday after Deutsche Bank upgraded the stock and raised its price target. The move comes ahead of key cancer study results set for release at the ASCO Genitourinary Cancers Symposium later this month. Merck’s chief marketing officer sold 10,000 shares on Feb. 12. U.S. markets are closed Monday for Washington’s Birthday; trading resumes Tuesday.
Spotify stock rebounds in after-hours as SPOT traders brace for holiday-thinned markets

Spotify stock rebounds in after-hours as SPOT traders brace for holiday-thinned markets

Spotify shares climbed 2.8% to $458.09 in after-hours trading Friday, rebounding from an 8.5% drop the previous day. The company reported 751 million monthly active users and 290 million premium subscribers for Q4, with €4.531 billion in revenue and €701 million operating income. Spotify forecast Q1 operating income above Wall Street estimates after price hikes and user growth. U.S. markets close Monday for Washington’s Birthday.
13 February 2026
Howmet stock price climbs as guidance beats estimates and Wall Street lifts targets

Howmet stock price climbs as guidance beats estimates and Wall Street lifts targets

Howmet Aerospace shares closed up 2.2% at $250.07 Friday after the company forecast higher-than-expected first-quarter earnings and reported a 15% jump in fourth-quarter revenue. CEO John Plant cited a record OEM backlog and strong gas turbine demand. About 2.5 million shares traded. Investors are watching the CAM acquisition timeline and the February 25 dividend payment.
TMUS stock jumps again as T-Mobile buyback plan and euro bond sale take center stage

TMUS stock jumps again as T-Mobile buyback plan and euro bond sale take center stage

T-Mobile shares closed up 2.25% at $219.52, holding gains after management raised parts of its 2026–27 outlook and doubled first-quarter share repurchase targets to $5 billion. The company’s T-Mobile USA unit agreed to sell €2.5 billion in senior notes, with proceeds possibly funding buybacks and refinancing. T-Mobile reported Q4 EPS of $1.88 and postpaid phone net adds of 962,000, but churn rose to 1.02%.
13 February 2026
Morgan Stanley CEO Ted Pick’s pay jumps to $45 million as Wall Street’s $40 million club expands

Morgan Stanley CEO Ted Pick’s pay jumps to $45 million as Wall Street’s $40 million club expands

Morgan Stanley approved $45 million in total compensation for CEO Ted Pick for 2025, up from $34 million in 2024, according to a Wednesday filing. Three-fourths of Pick’s pay is deferred over three years and tied to performance targets. The award follows record 2025 net revenue of $70.6 billion and net income of $16.9 billion. Pick’s package exceeds the $37 million paid to former CEO James Gorman for 2023.
13 February 2026
Ramil Palafox Jailed 20 Years as PGI Global’s $200 Million Bitcoin Ponzi Case Hits Sentencing

Ramil Palafox Jailed 20 Years as PGI Global’s $200 Million Bitcoin Ponzi Case Hits Sentencing

Ramil Ventura Palafox, ex-CEO of Praetorian Group International, was sentenced Thursday in Virginia to 20 years for running a $200 million bitcoin Ponzi scheme. Prosecutors said investors lost at least $62.7 million after putting in over $201 million between 2019 and 2021. The SEC has filed a parallel civil case alleging $198 million in crypto and forex fraud. Palafox pleaded guilty last September.
13 February 2026
Expedia stock (EXPE) slides 5% after outlook puts 2026 margins in the spotlight

Expedia stock (EXPE) slides 5% after outlook puts 2026 margins in the spotlight

Expedia shares fell 5% to $215.89 after the company forecast slower full-year margin gains despite strong bookings. Fourth-quarter revenue rose 11% to $3.55 billion, with gross bookings up 11% to $27 billion. The company declared a $0.48 dividend payable March 26 and reported $1.6 billion left for buybacks. Cantor cut its price target, citing ongoing concerns about AI risks.
13 February 2026
Roku stock price jumps as 2026 outlook tops estimates, putting ad growth back in focus

Roku stock price jumps as 2026 outlook tops estimates, putting ad growth back in focus

Roku shares jumped 9.3% to $90.67 Friday after the company set higher 2026 revenue and profit targets, reporting Q4 net revenue of $1.39 billion and net income of $80.5 million. Roku forecast 2026 net revenue of $5.5 billion and adjusted EBITDA of $635 million. Investors focused on platform revenue, which is expected to rise 18% to $4.89 billion. Attention turns to Q1 performance and ad demand through the Winter Olympics.
13 February 2026
Seagate (STX) stock turns choppy as $600 million notes exchange sets up next-week catalyst

Seagate (STX) stock turns choppy as $600 million notes exchange sets up next-week catalyst

Seagate shares edged up 0.1% to $431.46 Friday after swinging between $402.80 and $438.98. The company agreed to exchange $600 million in 3.50% exchangeable notes for nearly $599.2 million in cash and new shares, with settlement expected around Feb. 17. About $400 million in notes will remain outstanding. Investors await final details on the share issuance and upcoming investor events starting Feb. 25.
13 February 2026
FTSE 100 closes near record as deal buzz lifts London stocks — here’s what moved UK shares

FTSE 100 closes near record as deal buzz lifts London stocks — here’s what moved UK shares

The FTSE 100 closed up 0.42% at 10,446.35, near record highs, with deal activity and rate-cut bets offsetting AI disruption concerns. NatWest dropped 2.5% after posting £7.7 billion in 2025 pretax profit and announcing a £750 million buyback. Defence shares outperformed, while sterling headed for its biggest weekly loss versus the euro in over two months. Bank of England officials pushed back on rapid rate-cut expectations.
Eli Lilly stock price climbs as $1.5 billion pill stockpile sharpens focus on FDA April decision

Eli Lilly stock price climbs as $1.5 billion pill stockpile sharpens focus on FDA April decision

Eli Lilly shares rose 0.6% to $1,044.62 after the company disclosed $1.5 billion in pre-launch inventory for its experimental obesity pill, orforglipron, ahead of an expected FDA decision in April. The company also repurchased $4.1 billion in shares in 2025 and raised its quarterly dividend. Chinese regulators approved Lilly’s mirikizumab for Crohn’s disease and ulcerative colitis. U.S. stocks slipped in midday trading.
1 80 81 82 83 84 724

Stock Market Today

  • F&G Annuities Insider Buys $100,000 in Shares Amid Stock Slump
    March 28, 2026, 2:27 AM EDT. Celina J. Wang Doka, a director at F&G Annuities & Life, purchased 4,760 shares worth approximately $100,000, increasing her direct holdings by 17.43%. The insider bought shares at a $20.98 average price, below the March 16 closing price of $22.14, signaling confidence despite a 46.43% stock decline over the past year. This is her largest individual purchase, surpassing a 3,000-share buy in March 2025. The company's revenue stands at $5.4 billion with net income of $265 million and a 4% dividend yield. The shares have recovered about 15% since the purchase, suggesting a potential market rebound. F&G Annuities specializes in fixed annuities and life insurance, managing roughly $73 billion in assets under management.
Go toTop